Avicena has developed a scalable rapid molecular diagnostics platform that enables nations and organizations to quickly identify and contain potential outbreaks. Tony Fitzgerald, CEO, and Dr. Paul Watt, CSO, discuss how lessons learned from the pandemic have shaped their approach to building resilient systems capable of responding to the rapid spread of pathogens among humans and animals, helping safeguard global health.
